Christoph Driessen Selected Research

Extranodal NK-T-Cell Lymphoma

10/2018

Systemic treatment of a patient with relapsed and refractory extranodal NK/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph Driessen Research Topics

Disease

40	Multiple Myeloma 01/2023 - 04/2007
22	Neoplasms (Cancer) 10/2023 - 02/2008
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2019
6	Multiple Sclerosis 01/2009 - 11/2002
5	Infections 01/2023 - 04/2007
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2023 - 07/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 03/2016
2	Melanoma (Melanoma, Malignant) 10/2023 - 01/2019
2	COVID-19 01/2023 - 01/2023
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 08/2003
2	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016 - 08/2015
2	Hodgkin Disease (Hodgkin's Disease) 01/2008 - 01/2003
1	Pneumonia (Pneumonitis) 04/2024
1	Dysgeusia (Parageusia) 10/2023
1	Cytopenia 01/2023
1	Cytokine Release Syndrome 01/2023
1	cell-associated neurotoxicity 01/2023
1	Lactic Acidosis 10/2022
1	Plasma Cell Leukemia 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2021
1	Polycythemia Vera 10/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Residual Neoplasm 06/2020
1	Plasmacytoma 06/2020
1	Rheumatoid Arthritis 01/2020
1	Ankylosing Spondylitis 01/2020
1	Psoriatic Arthritis 01/2020

Drug/Important Bio-Agent (IBA)

22	Proteasome InhibitorsIBA 10/2023 - 02/2008
15	Bortezomib (Velcade)FDA Link 10/2023 - 07/2008
12	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 02/2008
7	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2016
6	Nelfinavir (Viracept)FDA Link 01/2023 - 03/2014
6	carfilzomibIBA 01/2023 - 08/2015
5	Immune Checkpoint InhibitorsIBA 04/2024 - 04/2019
5	HIV Protease InhibitorsIBA 01/2021 - 07/2008
5	AutoantigensIBA 01/2009 - 11/2002
5	Myelin Basic ProteinIBA 01/2009 - 11/2002
4	Peptide Hydrolases (Proteases)FDA Link 10/2008 - 05/2003
3	ibrutinibIBA 10/2023 - 05/2015
3	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 05/2015
3	Messenger RNA (mRNA)IBA 01/2023 - 05/2003
3	VaccinesIBA 01/2023 - 12/2021
3	Lenalidomide (CC 5013)FDA Link 11/2021 - 03/2017
3	ixazomibIBA 10/2021 - 10/2018
3	AntigensIBA 01/2021 - 04/2007
3	Dexamethasone (Maxidex)FDA LinkGeneric 06/2020 - 03/2017
3	invariant chain (Ii-Key)IBA 01/2020 - 05/2003
3	Monoclonal AntibodiesIBA 04/2019 - 01/2003
3	Rituximab (Mabthera)FDA Link 08/2015 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2017
2	AutoantibodiesIBA 04/2024 - 01/2020
2	AntibodiesIBA 04/2024 - 01/2023
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2023
2	Peptides (Polypeptides)IBA 07/2021 - 01/2020
2	EnzymesIBA 01/2020 - 12/2007
2	Phosphotransferases (Kinase)IBA 11/2019 - 04/2019
2	NivolumabIBA 07/2019 - 04/2019
2	Lopinavir FDA Link 01/2018 - 03/2014
2	Ritonavir (Norvir)FDA Link 03/2014 - 07/2008
2	CathepsinsIBA 05/2007 - 08/2003
1	Immunoglobulin G (IgG)IBA 04/2024
1	IgA receptor (protein B)IBA 04/2024
1	Interferon-gamma (Interferon, gamma)IBA 04/2024
1	Surface-Active Agents (Surfactants)IBA 04/2024
1	remdesivirIBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	pomalidomideIBA 01/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	molnupiravirIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	ProteomeIBA 01/2022
1	InterferonsIBA 10/2021
1	Interferon-alpha (Interferon Alfa)IBA 10/2021
1	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2021
1	melflufenIBA 07/2021
1	Membrane LipidsIBA 01/2021
1	EpitopesIBA 01/2021
1	LipidsIBA 01/2021
1	Prednisone (Sone)FDA LinkGeneric 06/2020
1	Melphalan (Alkeran)FDA LinkGeneric 06/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020

Therapy/Procedure

19	Therapeutics 04/2024 - 10/2006
3	Drug Therapy (Chemotherapy) 10/2023 - 06/2020
3	Immunotherapy 07/2019 - 04/2007
1	Acupressure (Shiatsu) 10/2023
1	Complementary Therapies (Alternative Medicine) 10/2023
1	Acupuncture Therapy 10/2023
1	Premedication 01/2023
1	Stem Cell Transplantation 06/2020
1	Surgical Instruments (Clip) 01/2020